New Taipei City | Date: November 5, 2024
YC Biotech CO., LTD. is proud to announce its expansion into Taipei Medical University’s Shuang Ho Biotech Park, with plans to develop state-of-the-art laboratories dedicated to driving innovation in precision medicine and regenerative medicine. This move signifies a significant step forward in the collaboration between YC Biotech, Taipei Medical University, and its affiliated hospitals, leveraging shared resources to foster industry-academia partnerships and advance medical technology, creating greater value for the biotechnology sector.
The Shuang Ho Biotech Park, established and operated by Taipei Medical University, is a dynamic innovation hub that integrates academic research, clinical applications, and industrial development. YC Biotech’s new presence in the park will include the construction of cutting-edge laboratories focusing on stem cell exosome research and cancer diagnostics. By utilizing the park’s advanced facilities and research platforms, YC Biotech aims to accelerate the research and development cycle, enhance the efficiency of technology transfer, and drive the clinical application and commercialization of its innovations.
YC Biotech considers its establishment in Shuang Ho Biotech Park a significant milestone in the company’s development, symbolizing the deepening of industry-academia collaboration and comprehensive enhancement of technological innovation capabilities. Moving forward, the company will maintain its focus on advancing research in precision medicine and regenerative medicine while working alongside domestic and international partners to promote progress in the biotechnology and medical fields, making greater contributions to global patient health and well-being.
Through its new base in Shuang Ho Biotech Park, YC Biotech plans to deepen collaboration with Taipei Medical University and its affiliated hospitals by integrating academic research with clinical resources. Together, they aim to create a comprehensive ecosystem encompassing academic research, clinical applications, and technology commercialization. This cross-disciplinary effort seeks to deliver safer, more effective healthcare solutions for patients while elevating Taiwan’s
biotechnology industry to new heights on the global stage.
For the latest updates, visit YC Biotech’s official website.
